Radiation Oncology, Treatment Protocols
Breast, Breast Metastatic
A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Permanently closed to accrual effective May 27, 2022. Phase IIR primary endpoint analysis is complete, and the results do not support reopening accrual to address the phase III research question.